| Literature DB >> 28959830 |
Rong Yuan1,2, Yan Wang1,2, Wei-Hong Cong2, Ke-Ji Chen2.
Abstract
Cardiovascular diseases have the characteristics of high morbidity and high mortality, and are recognized as the first cause of death by World Health Organization in World Health Statistics 2016. In recent years, traditional Chinese medicines have been widely applied in the treatment of cardiovascular diseases, while studies for integrated traditional Chinese and western medicines for treating cardiovascular diseases have made a great progress. Xiongshao capsule was developed by Academician Chen Keji according to classic formula Xuefu Zhuyu decoction and composed of effective parts of Rhizoma Ligusticum Wallichii and Radix Paeonia Rubra, with remarkable therapeutic effects on angina pectoris, restenosis after percutaneous coronary intervention(PCI), atherosclerosis, dyslipidemia and so on. In this review, basic and clinical studies for the effect of Xiongshao capsule in treating cardiovascular diseases were reviewed to provide reference for reasonable clinical use and example for new traditional Chinese medicine development and application under the guidance of theory of integrated traditional Chinese and western medicines. Copyright© by the Chinese Pharmaceutical Association.Entities:
Keywords: Xiongshao capsule ; atherosclerosis ; coronary heart disease(CHD) ; dyslipidemia ; percutaneous coronary intervention (PCI)
Mesh:
Substances:
Year: 2017 PMID: 28959830 DOI: 10.19540/j.cnki.cjcmm.2017.0017
Source DB: PubMed Journal: Zhongguo Zhong Yao Za Zhi ISSN: 1001-5302